Evonetix, the synthetic biology company bringing semiconductor technology to DNA synthesis, has achieved enzymatic DNA synthesis capability with its proprietary, thermally controlled synthesis chemistry. The culmination of a three-year development programme, supported by Innovate UK and in collaboration with Durham University, the results demonstrate that Evonetix’s unique, semi- conductor array-based platform is compatible with both […]

Arctoris, a tech-enabled biopharma company, and Evariste Technologies, an AI-drug discovery company, have formed a joint venture to identify novel small molecule kinase inhibitors for treatment of patients with Non-Small Cell Lung Cancer (NSCLC).

BioGenes and Alphalyse have been active in the field of Host Cell Protein (HCP) detection for many years and have now partnered up to offer their respective methods to biologics developers for optimal outcomes.

Leading researchers are warning of the dangers of a quiet epidemic of vitamin B12 deficiency in people who follow increasingly popular plant-based diets and explain how it can be addressed.

A common strategy to make vaccines more powerful is to deliver them along with an adjuvant – a compound that stimulates the immune system to produce a stronger response.